Initial antiretroviral therapy in chronically-infected HIV-positive adults

Zelalem Temesgen; Francesca Cainelli; David Warnke; Janak Koirala

doi:10.1517/14656566.5.3.595

Initial antiretroviral therapy in chronically-infected HIV-positive adults

Zelalem Temesgen, Francesca Cainelli, David Warnke, Janak Koirala

Infectious Diseases

Research output: Contribution to journal › Review article › peer-review

1 Scopus citations

Abstract

Currently, there are 20 individual antiretroviral drugs and two co-formulation products that are approved by the FDA for the treatment of HIV-infected individuals. It is widely accepted that the selection of an appropriate first-line regimen is critical in assuring durable treatment response. This article reviews the factors that should be considered in the selection of an initial antiretroviral regimen and present the currently available evidence regarding the status of individual antiretroviral agents and treatment strategies relative to these factors. 2004

Original language	English (US)
Pages (from-to)	595-612
Number of pages	18
Journal	Expert Opinion on Pharmacotherapy
Volume	5
Issue number	3
DOIs	https://doi.org/10.1517/14656566.5.3.595
State	Published - Mar 2004

Keywords

Antiretroviral drugs
Antiretroviral therapy
Highly active antiretroviral therapy (HAART)
Initial antiretroviral regimen

ASJC Scopus subject areas

Pharmacology
Pharmacology (medical)

Access to Document

10.1517/14656566.5.3.595

Cite this

@article{49e565e2921e4fd78cf8342716453912,

title = "Initial antiretroviral therapy in chronically-infected HIV-positive adults",

abstract = "Currently, there are 20 individual antiretroviral drugs and two co-formulation products that are approved by the FDA for the treatment of HIV-infected individuals. It is widely accepted that the selection of an appropriate first-line regimen is critical in assuring durable treatment response. This article reviews the factors that should be considered in the selection of an initial antiretroviral regimen and present the currently available evidence regarding the status of individual antiretroviral agents and treatment strategies relative to these factors. 2004",

keywords = "Antiretroviral drugs, Antiretroviral therapy, Highly active antiretroviral therapy (HAART), Initial antiretroviral regimen",

author = "Zelalem Temesgen and Francesca Cainelli and David Warnke and Janak Koirala",

year = "2004",

month = mar,

doi = "10.1517/14656566.5.3.595",

language = "English (US)",

volume = "5",

pages = "595--612",

journal = "Expert Opinion on Pharmacotherapy",

issn = "1465-6566",

publisher = "Informa Healthcare",

number = "3",

}

TY - JOUR

T1 - Initial antiretroviral therapy in chronically-infected HIV-positive adults

AU - Temesgen, Zelalem

AU - Cainelli, Francesca

AU - Warnke, David

AU - Koirala, Janak

PY - 2004/3

Y1 - 2004/3

N2 - Currently, there are 20 individual antiretroviral drugs and two co-formulation products that are approved by the FDA for the treatment of HIV-infected individuals. It is widely accepted that the selection of an appropriate first-line regimen is critical in assuring durable treatment response. This article reviews the factors that should be considered in the selection of an initial antiretroviral regimen and present the currently available evidence regarding the status of individual antiretroviral agents and treatment strategies relative to these factors. 2004

AB - Currently, there are 20 individual antiretroviral drugs and two co-formulation products that are approved by the FDA for the treatment of HIV-infected individuals. It is widely accepted that the selection of an appropriate first-line regimen is critical in assuring durable treatment response. This article reviews the factors that should be considered in the selection of an initial antiretroviral regimen and present the currently available evidence regarding the status of individual antiretroviral agents and treatment strategies relative to these factors. 2004

KW - Antiretroviral drugs

KW - Antiretroviral therapy

KW - Highly active antiretroviral therapy (HAART)

KW - Initial antiretroviral regimen

UR - http://www.scopus.com/inward/record.url?scp=1542609988&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1542609988&partnerID=8YFLogxK

U2 - 10.1517/14656566.5.3.595

DO - 10.1517/14656566.5.3.595

M3 - Review article

C2 - 15013928

AN - SCOPUS:1542609988

SN - 1465-6566

VL - 5

SP - 595

EP - 612

JO - Expert Opinion on Pharmacotherapy

JF - Expert Opinion on Pharmacotherapy

IS - 3

ER -

Initial antiretroviral therapy in chronically-infected HIV-positive adults

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this